We examined Bordetella avium for virulence factors common to Bordetella pertussis, including pertussis toxin, filamentous hemagglutinin, adenylate cyclase, dermonecrotic toxin, and tracheal cytotoxin. B. avium produced a dermonecrotic toxin and a tracheal cytotoxin. The dermonecrotic toxin of B. avium is a 155,000-molecular-weight, heat-labile protein which was lethal for mice, guinea pigs, young chickens, and turkey poults and produced dermonecrosis when injected intradermally into guinea pigs, chickens, and turkey poults. High-pressure liquid chromatography of B. avium culture supernatant fluid revealed the presence of a tracheal cytotoxin chemically identical to that produced by B. pertussis. B. avium isolates were negative for B. pertussis-like filamentous hemagglutinin and pertussis toxin when assayed with antibody against B. pertussis filamentous hemagglutinin and pertussis toxin. Furthermore, B. avium failed to induce the clustered CHO cell morphology characteristic of pertussis toxin. Adenylate cyclase assays indicated that B. avium does not produce an extracytoplasmic adenylate cyclase, even after passage through embryonated turkey eggs. Since production of virulence proteins by B. pertussis is regulated by growth in media containing nicotinamide or MgSO4 or by growth at reduced temperatures, we determined the eifect of these supplements and growth conditions on production of dermonecrotic toxin by B. avium. Production of dermonecrotic toxin in B. avium was not altered by growth in media containing 100 ,uM FeSO4 or 500 ,ig of nicotinamide per ml or by growth at 25 or 42°C, but production was significantly decreased by growth in media containing 20 mM MgSO4 and slightly reduced by growth in media containing 500 ,Ig of nicotinic acid per ml. These studies revealed that B. avium is similar to B. pertussis in that both species produce a dermonecrotic toxin and a tracheal cytotoxin and production of dermonecrotic toxin is regulated by nicotinamide and MgSO4. The presence of dermonecrotic toxin and tracheal cytotoxin in all Bordetella species indicates that these products may be important virulence factors in bordetellosis.
Bordetella avium is the etiological agent of rhinotracheitis of birds, a disease of the upper respiratory tract which resembles pertussis infection in humans (23, 29, 52) . Similarities between B. avium infection in birds and Bordetella pertussis infection in humans include a prolonged incubation period and similar clinical symptoms and histopathology. B. avium infection in birds initiates with an incubation period of 5 to 14 days, followed by clinical symptoms of depression, appetite loss, weight loss, coughing (snicking), mucous accumulation on the nares, and vocal alterations (6, 23, 38, 47, 51, 52) . Bordetellosis in both humans and fowl is characterized by a primary localized infection of the ciliated tracheal epithelial cells, often followed by life-threatening secondary infections (4, 6, 23, 33, 34, 38, 39, 46, 47, 52, 54, 56) . Histological examination of the trachea of diseased birds reveals pathological changes identical to those exhibited by tracheas from humans and hamster tracheal rings infected with B. pertussis (2, 6, 7, 16, 19, 38, 46, 47, 54) . Microscopic examination of the trachea reveals an initial bacterial colonization of the ciliated tracheal epithelial cells, followed by loss of ciliated cells and mucous accumulation. As with B. pertussis, B. avium has a specific tropism for ciliated respiratory epithelial cells, and isolation of B. avium from nonciliated respiratory epithelial cells in the lung and air sacs rarely occurs (19, 47 ; C. R. Gentry-Weeks and R. Curtiss III, MATERIALS AND METHODS Bacterial strains. The bacteria used in this study are listed in Table 1 . The causative agent of turkey coryza was recently reclassified from Alcaligenes faecalis to B. avium on the basis of DNA-rRNA hybridization studies, protein electropherogram analyses, and serological studies (11, 29) . Furthermore, B. avium isolates obtained from turkey flocks have been separated into two types, designated B. avium and B. avium-like on the basis of pathogenicity for turkey flocks, colony morphology, and fatty acid analysis (5, 27, 28, 35) . For consistency, the virulent type I isolates will be designated B. avium while the avirulent type II isolates will be designated B. avium-like throughout this paper. B. pertussis BB114 and B. pertussis Tohama III were maintained on Bordet-Gengou agar supplemented with 10% sheep blood, while B. avium isolates were maintained on brain heart infusion agar (BHI). When necessary, B. pertussis strains were grown in modified Stainer-Scholte broth (SSM) (20) B. AVIUM VIRULENCE FACTORS t699 (10 ,ug/ml), and L-phenylalanine (20 P,g/ml; SSM-S). Reagents and media. Dermonecrotic toxin antibody was prepared by injection of partially purified dermonecrotic toxin into New Zealand White rabbits (43) . This antibody preparation neutralized dermonecrotic toxin from B. avium sonicates (43) . Goat pertussis toxin antibody and goat filamentous hemagglutinin antibody were kindly provided by James Cowell (48 (10) . Cell homogenates of B. pertussis strains BB114 and Tohama III served as positive and negative controls, respectively. Briefly, B. avium and B. pertussis strains were passaged twice in 25 ml of SSM-S and SSM media, respectively, prior to the skin test. The cells were grown to late-log phase (optical density at 540 nm, 1.1), pelleted, suspended in 1/12 the original volume of 10 mM Tris (pH 7.5), and exposed to lysozyme and EDTA to facilitate lysis. Cells were lysed by homogenization for 2.0 min by using 150-to 200-,umdiameter glass beads (Sigma, type III-W) in a cell homogenizer (B. Braun, Melsungen AG, Federal Republic of Germany), with a CO2 cooling system. Deoxyribonuclease and MgCl2 were added to the cell lysate, and the mixture was incubated for 15 min. Cell debris was removed by centrifugation of the cell homogenate, and the supernatant fluid was filtered through a Nalgene filter (pore size, 0.45 ,um). Cell lysis was monitored by determining the titer of the cells before and after homogenization. White Hartley guinea pigs (weight, 400 g) were injected intradermally with 80-pd samples of the crude cell homogenates (from 0.5 x 109 to 1.0 x 109 lysed cells) and were observed for dermonecrosis after 24 h. Since the dermonecrotic toxin from B. pertussis is inactivated by heat treatment at 56°C for 10 min, B. avium cell homogenates were treated similarly to test for heat lability and were injected intradermally into depilated guinea pigs.
Cell homogenates were tested for lethality for BALB/c mice. B. avium 197 and B. avium-like 008 cell homogenates from 1 x 109 to 3 x 109 lysed cells were injected intraperitoneally into 4-week-old BALB/c mice. Mouse were denatured by boiling in sample buffer and were electrophoresed through sodium dodecyl sulfate-7.5% polyacrylamide gels, and proteins were transferred to nitrocellulose by using established methods (55) . Nitrocellulose filters were incubated with rabbit antibody against B. avium dermonecrotic toxin, washed with blocking buffer (described above), incubated with horseradish peroxidase-conjugated, affinity-purified goat anti-rabbit immunoglobulin G antibody, and developed as described in the previous section.
Regulation of production of dermonecrotic toxin. B. avium cultures were grown overnight at 37°C in SSM-S medium supplemented with 100 ,uM FeSO4 and containing either 500
Rg of nicotinamide per ml or 500 ,ug of nicotinic acid per ml.
In addition, B. avium 197 was grown at 37°C in SSM-S medium which lacked NaCl, was supplemented with 20 mM MgSO4, and contained either 500 ,ug of nicotinic acid per ml or 500 ,ug of nicotinamide per ml. Finally, B. avium 197 was grown at 25, 37, or 42°C in SSM-S medium containing either 500 ,ug of nicotinamide per ml or 500 ,ug of nicotinic acid per ml. All overnight cultures of B. avium 197 were grown to stationary phase (optical density at 540 nm, 1.5), and the titers were determined. Each culture (100 ,ul, containing between 5 x 108 and 10 x 108 cells) was denatured by boiling in sample buffer, electrophoresed through a sodium dodecyl sulfate-7.5% polyacrylamide gel, and transferred to a nitrocellulose filter. The nitrocellulose filter was incubated with rabbit antibody against B. avium dermonecrotic toxin, reacted with goat anti-rabbit peroxidase conjugate, and developed with 4-chloro-1-naphthol as described above. RESULTS Dermonecrotic toxin assay. B. avium isolates were tested for dermonecrotic toxin by intradermal injection of cell homogenates containing 0.5 x 109 to 1 x 109 lysed cells into depilated guinea pigs. Cell homogenates from virulent, latelog-phase B. avium produced a nonulcerating dermonecrosis in guinea pigs ( Fig. 1) avium 197 containing 1 x 109 to 3 x 109 lysed cells were injected intradermally into turkey and chicken poults, while injection of B. avium-like 008 cell homogenates had no effect. The dermonecrotic lesion produced by injection of cell homogenates into turkeys and chickens was much more extensive and comprised an area two to five times larger than the lesions produced in guinea pigs.
Since dermonecrotic toxin of B. pertussis causes lethality in mice (34) , BALB/c mice were injected intraperitoneally with 100 ,u1 of 1 x 109 to 3 x 109 homogenized B. avium or B. avium-like cells to confirm the presence of a mouse lethal toxin. Mice injected intraperitoneally with cell homogenates from virulent B. avium 197 died within 24 h postinjection, while mice injected with cell homogenates of B. avium-like 008 survived with no ill effects.
Intradermal injection of cell homogenates from virulent B. avium 197 was lethal for 3-day-old turkey poults and 2-weekold chickens. However, injection of an equivalent amount of the B. avium 197 cell homogenate into 3-week-old turkey poults did not result in poult death, indicating that the weight or age of the bird was important in determining the susceptibility to the lethal effects of the toxin.
The dermonecrosis and lethality caused by cell homogenates of B. avium isolates 197 and 4671 were eliminated by heating the cell homogenates for 15 min at 56°C (Fig. 1) . Treatment of B. pertussis cell homogenates for 15 min at 56°C resulted in only partial elimination of dermonecrosis (Fig. 1, row B (Fig. 2) . To determine whether the dermonecrotic toxin of B. avium is immunologically crossreactive with dermonecrotic toxins described for other Bordetella species, whole cells from B. pertussis BB114, B. pertussis Tohama III, B. bronchiseptica 469, and B. aviumlike 008 were subjected to Western blot analysis by using antibody against B. avium dermonecrotic toxin (Fig. 2) contain proteins which cross-reacted with significant intensity with the antiserum against dermonecrotic toxin. All Bordetella species were found to produce a 58,000-molecular-weight protein which cross-reacted with dermonecrotic toxin antibody. However, the 58,000-molecular-weight protein was also present in Escherichia coli cells (data not shown), suggesting that the 58,000-molecular-weight protein was a common bacterial protein and was unrelated to dermonecrotic toxin. Therefore, cross-reactivity of dermonecrotic toxin antibody with the 58,000-molecular-weight protein probably represented nonspecific, naturally acquired, cross-reactive antibody in the rabbit antiserum.
Regulation of dermonecrotic toxin production by B. avium. Previous investigators have studied the effect of different growth media or reduced growth temperatures on dermonecrotic toxin production by B. pertussis (32, 40, 49) . Similarly, dermonecrotic toxin production by B. avium 197 was monitored by immunoblot analysis of B. avium cells grown under various conditions (Fig. 3) to determine whether regulation of toxin production in B. avium mimics regulation of B. pertussis dermonecrotic toxin production. Nicotinamide and nicotinic acid equally increased the growth rate of B. avium 197 but did not eliminate production of the dermonecrotic toxin. Growth with 500 ,ug of nicotinic acid per ml (Fig. 3, lane 7) caused a slight decrease in production of dermonecrotic toxin as compared with that when cells were FIG. 3 . Immunoblot analysis of the regulation of B. avium dermonecrotic toxin production by growth conditions with antibody against B. avium dermonecrotic toxin. B. avium 197 was grown at 37°C in SSM-S medium containing 500 ,ug of nicotinamide per ml (lane 2), 500 p,g of nicotinamide per ml and 100 ,uM FeSO4 (lane 3), or 500 ,ug of nicotinamide per ml and 20 mM MgSO4 and lacking NaCl (lane 4). B. avium 197 cells were also grown at 25°C in SSM-S medium supplemented with 500 ,ug of nicotinamide per ml (lane 5) or at 42°C in SSM-S medium supplemented with 500 ,ug of nicotinamide per ml (lane 6). Lanes 7 through 11 contain B. avium 197 cells grown under identical conditions as specified for lanes 2 through 6, respectively, except that nicotinic acid (500 jig/ml) was substituted for nicotinamide. Lane 1 contains prestained molecular weight markers (SDS-7B; Sigma). grown with 500 ,ug of nicotinamide per ml (lane 2). Production of dermonecrotic toxin by B. avium 197 was significantly reduced by growth in medium supplemented with 20 mM MgSO4 and lacking NaCl, as evidenced by reduced immunological cross-reactivity of cell homogenates with specific dermonecrotic toxin antibody in immunoblots (Fig.  3, lane 4) . The addition of FeSO4 (final concentration, 100 ,uM) to the growth medium did not significantly alter toxin production, and growth of B. avium 197 at 25, 37, or 42°C produced comparable results and did not affect toxin production.
Tracheal cytotoxin assay. Culture supernatant fluids from B. avium and B. avium-like isolates were analyzed for the presence of a glycopeptide similar to the tracheal cytotoxin (TCT) produced by B. pertussis and B. bronchiseptica (8, 17, 45) . HPLC analysis revealed the presence of a molecule in B. avium 197 and B. avium-like 008 culture supernatant fluids which was chemically indistinguishable from the tracheal cytotoxin produced by B. pertussis BB114. This was confirmed by identical retention times in two different reversedphase HPLC systems (triethylamine and trifluoroacetic acidbuffered mobile phases); data for one of these analyses are shown in Fig. 4 Table 2 . To examine the possibility that the adenylate cyclase of B. avium might be induced by environmental conditions, B. avium isolates were passaged through 8-day-old embryonated eggs and assayed again for extracytoplasmic adenylate cyclase. Egg passage had no effect on the assay, i.e., egg-passaged B. avium did not produce detectable extracytoplasmic adenylate cyclase (Table 2) . Pertussis toxin assay. Since pertussis toxin is an important virulence factor for B. pertussis (34, 39, 58) , B. avium and B. avium-like isolates were examined for pertussis toxin by using the CHO cell-clustering assay, colony immunoblot assay, and the ability to hemagglutinate goose RBCs, all of which are properties associated with pertussis toxin of*B. pertussis (25, 48) . CHO cells exposed to B. avium culture supernatant fluid did not exhibit the clustering effect induced by B. pertussis culture supernatant fluid which contained pertussis toxin (Fig. 5) . B. avium isolates were unable to hemagglutinate goose RBCs under any of the conditions tested, i.e., growth medium, egg passage, or assay temperature did not alter the outcome of the hemagglutination reactions. To determine whether B. avium produced a protein which cross-reacted with pertussis toxin from B. pertussis but lacked hemagglutinating activity, B. avium isolates were reacted with pertussis toxin antibody (Fig. 6) in colony immunoblot assays. Although B. pertussis reacted intensely with the pertussis toxin antibody, the B. avium isolates failed to cross-react. It is possible, however, that the sensitivity of the colony immunoblot assay is too low to detect cross-reactive protein in strains which produce very low levels of the protein in vitro.
Filamentous hemagglutinin assay. The filamentous hemagglutinin of B. pertussis is responsible for adherence of B. pertussis to human ciliated tracheal epithelial cells (for reviews, see references 34 and 58) and agglutinates goose RBCs (25, 48) . Goose RBCs were not agglutinated by B. avium isolates which were grown on BHI agar, BordetGengou agar containing 10% sheep blood, or colonization factor antigen agar or which were egg passaged. In addition to the hemagglutination assays, colony immunoblots were performed by using specific polyclonal antibody (provided by J. Cowell) against B. pertussis filamentous hemagglutinin (Fig. 6) to determine whether B. avium produces a protein analogous to the filamentous hemagglutinin of B. pertussis. As expected, B. pertussis reacted intensely with the antiserum for B. pertussis filamentous hemagglutinin. However, there was no cross-reactivity between the B. avium isolates VOL. 56, 1988 on December and the filamentous hemagglutinin antibody. As mentioned above, this assay may not detect strains that produce low levels of protein which cross-reacts with the antibody.
Hemagglutination of guinea pig RBCs. B. avium was tested for the ability to agglutinate guinea pig RBCs since agglutination of guinea pig RBCs has been reported to be associated with virulence for turkey poults (28) . All virulent B. avium isolates tested were positive for agglutination of guinea pig RBCs, while avirulent B. avium-like isolates failed to agglutinate guinea pig RBCs. Virulent B. avium isolates grown at 25 or at 37°C on BHI agar or Bordet-Gengou agar containing 10% sheep blood or without egg passage still agglutinated guinea pig RBCs. DISCUSSION B. avium produces a dermonecrotic toxin and a tracheal cytotoxin, two virulence factors common to all Bordetella species. Virulent B. avium isolates produced a cell-associated, 155,000-molecular-weight protein which was similar in biological activity to the dermonecrotic toxin of B. pertussis and B. bronchiseptica. The dermonecrotic toxin of B. avium was heat labile and trypsin, formaldehyde, and glutaraldehyde sensitive, and it produced nonulcerating, dermonecrotic lesions in guinea pigs and turkeys which were identical to lesions produced by B. bronchiseptica and B. pertussis. These results are similar to those obtained by Rimler and Rhoades (41, 42, 43) . B. bronchiseptica, B. pertussis, and Bordetella parapertussis dermonecrotic toxins are reported to be serologically related (30) , and molecular weights of 102,000 (36) and 190,000 (30) for the dermonecrotic toxin of B. bronchiseptica have been reported by different investigators. In addition, treatment of the 190,000-molecular-weight dermonecrotic toxin of B. bronchiseptica with trypsin, dithiothreitol, and urea results in the formation of two peptides with molecular weights of approximately 118,000 and 75,000 (30) . Antibody against the dermonecrotic toxin of B. avium cross-reacted intensely with a 76,000-molecular-weight protein of B. pertussis. These results suggest that the dermonecrotic toxin of B. avium and B. pertussis share a common antigenic determinant(s). However, antibody against the dermonecrotic toxin of B. avium failed to cross-react with B. bronchiseptica 469. In addition, of four B. bronchiseptica isolates tested, only one isolate (B. bronchiseptica 40-81) was found to produce a 190,000-molecular-weight protein which cross-reacted with antibody against the B. avium dermonecrotic toxin (data not shown), and this isolate had been isolated from the trachea of a turkey (29 on the production of dermonecrotic toxin by B. pertussis are controversial (40, 49) . Production of dermonecrotic toxin by B. avium was slightly suppressed but not eliminated by growth in nicotinic acid, while growth with nicotinamide at 37°C was optimum for dermonecrotic toxin production. These results parallel those of Schneider and Parker (49) , who reported that B. pertussis cells grown in nicotinic acid produce very low levels of dermonecrotic toxin activity. In analogy with growth of B. pertussis (32) , growth of B. avium in MgSO4 resulted in a substantial decrease in dermonecrotic toxin production, while addition of FeSO4 to the growth medium (57) did not alter dermonecrotic toxin production. These results indicate that regulation of dermonecrotic toxin in B. avium is similar to regulation of dermonecrotic toxin in B. pertussis. The effect of reduced growth temperature on the production of B. pertussis dermonecrotic toxin has not been reported. Growth of B. avium at 25 or 42°C did not alter dermonecrotic toxin production, and the amount of dermonecrotic toxin produced at these temperatures was comparable to the amount of dermonecrotic toxin produced at 37°C.
The exact role of the dermonecrotic toxin in the pathogenicities of B. avium and B. pertussis is unknown. It has been reported that the dermonecrotic toxin of B. pertussis inhibits a Na+-K+-ATPase in in vitro assays (36) and causes contraction of the smooth muscles surrounding peripheral blood vessels, resulting in vasoconstriction and increased perfusion pressure in perfused lungs from guinea pigs (12, 13) .
Furthermore, it has been proposed that the vasoconstriction induced by the toxin is responsible for the splenic atrophy of mice injected with B. pertussis dermonecrotic toxin (24, 36) . In addition, it has been reported that the dermonecrotic toxins of B. avium and B. pertussis have no effect on the ciliary activity of cultured tracheal rings from turkeys and hamsters, respectively (13, 17, 43) . However, conservation of a functional dermonecrotic toxin in all Bordetella species suggests that this toxin may play a role in the virulence of the organisms (for a review, see reference 30).
A tracheal cytotoxin which is chemically identical to the tracheal cytotoxin of B. pertussis was produced by B. avium isolates. Since in vitro studies with B. pertussis tracheal cytotoxin have demonstrated specific damage to ciliated epithelial cells (16, 17) , it has been proposed that the tracheal cytotoxin of B. pertussis is responsible for poor mucous clearance and increased susceptibility to infection with secondary bacterial pathogens. Similarly, tracheas from B. avium-infected turkeys exhibit loss of ciliated tracheal epithelial cells (2, 6, 18, 38, 46, 47) , and death of infected turkeys is commonly due to infections with opportunistic pathogens (4, 46) or by suffocation due to the inability to clear the airways (6, 19) . The similarity of histopathology and symptoms of Bordetella infection in humans and birds and the existence of the tracheal cytotoxin in all Bordetella species (8) (26) . Furthermore, B. avium pili do not have hemagglutinating activity (26, 53) , and therefore, it is unlikely that guinea pig hemagglutinin is involved directly in adherence.
In contrast with the other Bordetella species (22, 37) , B. avium did not produce an extracytoplasmic adenylate cy-VOL. 56, 1988 on December 21, 2017 by guest http://iai.asm.org/ clase when grown in vitro. Passage of B. avium through embryonated eggs before the assay was done did not increase the expression or activity of adenylate cyclase of B. avium grown in vitro. Since the other Bordetella species produce adenylate cyclase and cause disease in mammals and B. avium produces disease in birds, it is possible that in adaptation to the bird host, B. avium lost the genes or the ability to express adenylate cyclase.
The results of this study indicated that in analogy with B. pertussis, virulent B. avium produces two putative virulence factors, a dermonecrotic toxin and a tracheal cytotoxin. Furthermore, all species of Bordetella which cause disease in animals produce dermonecrotic toxin and tracheal cytotoxin. In contrast with B. pertussis, B. avium did not express proteins which are functionally or immunologically common to B. pertussis, such as the pertussis toxin, the filamentous hemagglutinin, or the adenylate cyclase. While B. pertussis, B. parapertussis, and B. bronchiseptica produce adenylate cyclase, B. pertussis is the sole producer of pertussis toxin. Lack of virulence factors in B. avium common to B. pertussis may merely reflect differences in physiology, receptors, and immune networks of the host species. However, since in both birds and humans, the disease process includes prolonged incubation periods, an infection localized to the upper respiratory tract, loss of tracheal epithelial cells, and life-threatening secondary infections, further investigations into the roles and biological activities of the dermonecrotic toxin and the tracheal cytotoxin are merited. It is not unreasonable to expect that evolutionarily conserved toxins are likely to be responsible for the common pathology in infections by all Bordetella species. Finally, in addition to the dermonecrotic toxin and tracheal cytotoxin, a heatstable toxin produced by B. avium has been described which is lethal when injected intraperitoneally into mice (50) . Examination of other Bordetella strains may reveal the existence of a similar toxin. Therefore, further study of B. avium virulence factors may provide insight into the pathogenicity of other Bordetella species.
